Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose study of Pha-794428 in adult growth hormone deficient patients
2005-005587-82Phase 2Terminated
- Start
- Mar 2006
- Modality
- PEGylated Peptides → Modified Peptides → Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PHA-794428 in adult onset growth hormone deficiency (AGHD) and growth hormone deficiency (GHD). Primary endpoints: Responder status at week 4 (visit 9) and Responder status at week 7 (visit 14). Started Mar 2006; status: terminated.
02
Drugs
PHA-794428
03
Conditions
adult onset growth hormone deficiency (AGHD)growth hormone deficiency (GHD)
Beyond the preview
Go deeper on 2005-005587-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005587-82.